TG Therapeutics, Inc.TGTXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+34.4%
5Y CAGR+16.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+34.4%/yr
vs +58.4%/yr prior
5Y CAGR
+16.5%/yr
Recent acceleration
Acceleration
-24.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $231.91M | +50.3% |
| 2024 | $154.30M | +25.7% |
| 2023 | $122.71M | +28.5% |
| 2022 | $95.48M | -25.5% |
| 2021 | $128.09M | +18.8% |
| 2020 | $107.85M | +617.7% |
| 2019 | $15.03M | -0.9% |
| 2018 | $15.16M | -7.2% |
| 2017 | $16.33M | +65.1% |
| 2016 | $9.89M | - |